236 related articles for article (PubMed ID: 35028852)
1. Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia.
Dancik GM; Voutsas IF; Vlahopoulos S
Mol Biol Rep; 2022 Apr; 49(4):3321-3331. PubMed ID: 35028852
[TBL] [Abstract][Full Text] [Related]
2. The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia.
Dancik GM; Varisli L; Vlahopoulos SA
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298333
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells.
Dancik GM; Voutsas IF; Vlahopoulos S
Front Biosci (Schol Ed); 2022 Mar; 14(1):8. PubMed ID: 35320919
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid Leukemia.
Dancik GM; Varisli L; Tolan V; Vlahopoulos S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761947
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
Elcheva IA; Wood T; Chiarolanzio K; Chim B; Wong M; Singh V; Gowda CP; Lu Q; Hafner M; Dovat S; Liu Z; Muljo SA; Spiegelman VS
Leukemia; 2020 May; 34(5):1354-1363. PubMed ID: 31768017
[TBL] [Abstract][Full Text] [Related]
6. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
[TBL] [Abstract][Full Text] [Related]
7. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
8. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
[TBL] [Abstract][Full Text] [Related]
9. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers.
Gasparetto M; Smith CA
Chem Biol Interact; 2017 Oct; 276():46-51. PubMed ID: 28645468
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
[TBL] [Abstract][Full Text] [Related]
11. Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
Pandrangi SL; Chikati R; Chauhan PS; Kumar CS; Banarji A; Saxena S
Tumour Biol; 2014 Jan; 35(1):723-37. PubMed ID: 23982874
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.
Man CH; Fung TK; Ho C; Han HH; Chow HC; Ma AC; Choi WW; Lok S; Cheung AM; Eaves C; Kwong YL; Leung AY
Blood; 2012 May; 119(22):5133-43. PubMed ID: 22368270
[TBL] [Abstract][Full Text] [Related]
13. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
[TBL] [Abstract][Full Text] [Related]
14. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
15. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
[TBL] [Abstract][Full Text] [Related]
16. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
17. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.
Qian X; Wagner S; Ma C; Coordes A; Gekeler J; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1151-8. PubMed ID: 24770634
[TBL] [Abstract][Full Text] [Related]
19. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
[TBL] [Abstract][Full Text] [Related]
20. ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.
Song YH; Zhong MZ; Gan PP; Yi PY; Tang YH; Liu YP; Jiang JQ; Li L
Tumour Biol; 2014 Dec; 35(12):11809-17. PubMed ID: 25344211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
